Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.

Tremoulet AH, Capparelli EV, Patel P, Acosta EP, Luzuriaga K, Bryson Y, Wara D, Zorrilla C, Holland D, Mirochnick M. Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants. Antimicrob Agents Chemother. 2007 Dec; 51(12):4297-302.

View in: PubMed

subject areas

Anti-HIV Agents
Area Under Curve
Clinical Trials as Topic
Creatinine
Drug Administration Schedule
Female
HIV
HIV Infections
Humans
Infant
Infant, Newborn
Lamivudine
Male
Meta-Analysis as Topic
Metabolic Clearance Rate

authors with profiles

Carmen D. Zorrilla

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support